Today: 10 June 2026
BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus
23 January 2026
1 min read

BigBear.ai (BBAI) stock flat after SEC filing delays share vote again; CargoSeer deal in focus

New York, Jan 23, 2026, 12:53 EST — Regular session

  • BigBear.ai announced the shareholder vote to double its authorized common stock has been delayed to Feb. 18, with voting open through Feb. 17.
  • This week, the company revealed it acquired specific CargoSeer technologies focused on cargo inspection and trade-risk management.

BigBear.ai Holdings shares barely moved Friday after the company delayed a shareholder vote yet again. The vote concerns a proposal to double its authorized common stock to 1 billion shares. Electronic voting remains open through Feb. 17, ahead of the reconvened meeting set for Feb. 18, according to an SEC filing. The stock last dipped about 0.1% to $5.93, having fluctuated between $5.76 and $6.03 during the session, with around 39 million shares changing hands.

The vote is crucial since “authorized shares” define the legal limit on how many shares a company can issue. Increasing that limit doesn’t dilute investors on its own, but it opens the door for fresh fundraising, stock-based compensation, or shares used in acquisitions.

It’s concrete for BigBear.ai at the moment. The McLean, Virginia-based firm revealed late Wednesday it picked up specific technologies from CargoSeer, Ltd., a company specializing in cargo scanning and trade risk management software. The purchase price wasn’t disclosed.

CargoSeer’s platform focuses on “non-intrusive inspection,” using imaging systems to scan cargo without opening containers. It combines automated image analysis, computer vision, and machine learning with trade and cargo data, the companies said. BigBear.ai CEO Kevin McAleenan noted the acquisition will help “support customs agencies.” Meanwhile, CargoSeer co-founder and CEO David Smason expects the technology to “scale rapidly.” Business Wire

Broader U.S. stocks were creeping up during the session, with the SPDR S&P 500 ETF ticking up roughly 0.1% and the Invesco QQQ Trust gaining around 0.4%.

AI-linked stocks showed a split performance. Palantir Technologies climbed roughly 2.8%, but C3.ai edged down by about 0.9%.

For small, volatile stocks, these share-vote developments can still pack a punch, even if the price barely shifts. Investors see them as clues about how much equity the board plans to hold back—and their reasons for doing so.

The deal has its downsides. Buying CargoSeer brings integration risks and, so far, limited concrete data. The longer the vote on share authorization drags out, the more concerns about dilution could mount. On another front, Pomerantz Law Firm announced Thursday it’s investigating claims on behalf of BigBear.ai investors.

Traders are focused on one key date: Feb. 18. That’s when the company’s Proposal 1 vote happens. They’ll also be looking for any follow-up disclosures to clarify exactly what the CargoSeer assets bring to the table — and their price tag.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week
Previous Story

UnitedHealth stock price today: UNH steadies near $355 after Obamacare rebate pledge, with earnings next week

HBAN stock slips as Huntington tees up new debt sale ahead of Cadence deal — what to watch next week
Next Story

HBAN stock slips as Huntington tees up new debt sale ahead of Cadence deal — what to watch next week

Go toTop